The transjugular intrahepatic portosystemic shunt (TIPS) represents a key intervention for portal hypertension (PH) complications. However, the epidemiology of chronic liver disease has changed substantially, with diabetes, obesity, and metabolic dysfunction–associated steatotic liver disease (MASLD) now representing the leading etiologies [1]. In this evolving context, TIPS indications and outcomes must be carefully reassessed.
TIPS in the Era of Aging and Metabolic Comorbidity: Rethinking Risks and Rewards / Roccarina, Davide; La Delfa, Rosario; Vizzutti, Francesco. - In: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. - ISSN 0269-2813. - ELETTRONICO. - (2026), pp. 0-0. [10.1111/apt.70496]
TIPS in the Era of Aging and Metabolic Comorbidity: Rethinking Risks and Rewards
Roccarina, Davide;La Delfa, Rosario;Vizzutti, Francesco
2026
Abstract
The transjugular intrahepatic portosystemic shunt (TIPS) represents a key intervention for portal hypertension (PH) complications. However, the epidemiology of chronic liver disease has changed substantially, with diabetes, obesity, and metabolic dysfunction–associated steatotic liver disease (MASLD) now representing the leading etiologies [1]. In this evolving context, TIPS indications and outcomes must be carefully reassessed.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Aliment Pharmacol Ther - 2026 - Roccarina - Editorial TIPS in the Era of Aging and Metabolic Comorbidity Rethinking Risks (1).pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
278.83 kB
Formato
Adobe PDF
|
278.83 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
